The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sangamo BioSciences Inc

Nasdaq: SGMO
Last

(U.S.) $6.02

Today's change+0.23 +3.97%
Updated July 1 4:00 PM EDT. Delayed by at least 15 minutes.
 

Sangamo BioSciences Inc

Nasdaq: SGMO
Last

(U.S.) $6.02

Today's change+0.23 +3.97%
Updated July 1 4:00 PM EDT. Delayed by at least 15 minutes.

Sangamo BioSciences Inc up sharply

Sangamo BioSciences Inc closed up sharply Friday, rallying (U.S.)$0.23 or 3.97% to (U.S.)$6.02. Over the last five days, shares have gained 9.26%, but are down 34.06% for the last year to date. Shares have underperformed the S&P 500 by 41.98% during the last year.

Key company metrics

  • Open(U.S.) $5.76
  • Previous close(U.S.) $5.79
  • High(U.S.) $6.05
  • Low(U.S.) $5.71
  • Bid / Ask(U.S.) $0.00 / (U.S.) $6.10
  • YTD % change-34.06%
  • Volume708,653
  • Average volume (10-day)843,498
  • Average volume (1-month)798,732
  • Average volume (3-month)861,311
  • 52-week range(U.S.) $4.63 to (U.S.) $11.28
  • Beta2.27
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.74
Updated July 1 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.20%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue4998
Total other revenue--------
Total revenue4998
Gross profit--------
Total cost of revenue--------
Total operating expense21252121
Selling / general / administrative5555
Research & development15201716
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-17-16-13-12
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-16-16-13-12
Income after tax-16-14-9-12
Income tax, total0-2-30
Net income-16-14-9-12
Total adjustments to net income--------
Net income before extra. items-16-14-9-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-16-14-9-12
Inc. avail. to common incl. extra. items-16-14-9-12
Diluted net income-16-14-9-12
Dilution adjustment--------
Diluted weighted average shares70707070
Diluted EPS excluding extraordinary itemsvalue per share-0.23-0.20-0.13-0.17
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.23-0.20-0.13-0.17